Is Broadcom Stock a Millionaire Maker?
Broadcom (Nasdaq: AVGO) stock has gone up more than 64%…
Buy
57
KNBWY Quote, Financials, Valuation and Earnings
Last price:
$14.95
Seasonality move
:
-0.95%
Day range:
$15.02 - $15.25
52-week range:
$12.25 - $16.25
Dividend yield:
3.21%
P/E ratio:
14.65x
P/S ratio:
0.80x
P/B ratio:
1.48x
Volume:
23.1K
Avg. volume:
34.8K
1-year change:
0.47%
Market cap:
$12.2B
Revenue:
$15.5B
EPS (TTM):
$0.89
Analysts' Opinion
-
Consensus RatingKirin Holdings has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $16.60, Kirin Holdings has an estimated upside of 10.52% from its current price of $15.02.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $16.60 representing 100% downside risk from its current price of $15.02.
Fair Value
-
According to the consensus of 1 analyst, Kirin Holdings has 10.52% upside to fair value with a price target of $16.60 per share.
KNBWY vs. S&P 500
-
Over the past 5 trading days, Kirin Holdings has underperformed the S&P 500 by -2.83% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Kirin Holdings does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Kirin Holdings has grown year-over-year revenues for 2 quarters straight. In the most recent quarter Kirin Holdings reported revenues of $4.1B.
Earnings Growth
-
Kirin Holdings earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Kirin Holdings reported earnings per share of $0.18.
Enterprise value:
19.6B
EV / Invested capital:
--
Price / LTM sales:
0.80x
EV / EBIT:
11.21x
EV / Revenue:
1.30x
PEG ratio (5yr expected):
0.29x
EV / Free cash flow:
47.73x
Price / Operating cash flow:
11.99x
Enterprise value / EBITDA:
8.33x
Gross Profit (TTM):
$7B
Return On Assets:
3.52%
Net Income Margin (TTM):
4.72%
Return On Equity:
7.26%
Return On Invested Capital:
4.8%
Operating Margin:
7.02%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $15.7B | $15B | $15.2B | $4B | $4.1B | |
| Gross Profit | $7.1B | $6.8B | $7B | $1.8B | $1.9B | |
| Operating Income | $893.3M | $705.8M | $1.1B | $521.7M | $285.3M | |
| EBITDA | $2.3B | $1.6B | $2.1B | $759.7M | $509.5M | |
| Diluted EPS | $1.27 | $0.58 | $0.89 | $0.44 | $0.18 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $7.5B | $7.3B | $5.9B | $6.7B | $7.2B | |
| Total Assets | $22.9B | $21.5B | $18.1B | $19.7B | $22.8B | |
| Current Liabilities | $6.7B | $5.1B | $4.4B | $5.8B | $6.1B | |
| Total Liabilities | $12.7B | $11.5B | $9.1B | $10.3B | $12.3B | |
| Total Equity | $10.2B | $10B | $9B | $9.3B | $10.6B | |
| Total Debt | $6.6B | $5.4B | $3.9B | $5B | $6.3B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $1B | $1.4B | -- | $562.2M | $402.7M | |
| Cash From Investing | -$79.7M | -$1.6B | -- | -$12.3M | -$429.9M | |
| Cash From Financing | -$1.3B | $255.9M | -- | -$641.6M | -$289.5M | |
| Free Cash Flow | $284.4M | $637.2M | -- | $329.2M | -- | |
KNBWY
Sector
Market Cap
$12.2B
$257.3M
Price % of 52-Week High
92.43%
73.99%
Dividend Yield
3.21%
0%
Shareholder Yield
1.56%
3.16%
1-Year Price Total Return
0.47%
-10.07%
Beta (5-Year)
0.153
0.395
Dividend yield:
3.21%
Annualized payout:
$0.48
Payout ratio:
56.26%
Growth streak:
1 years
Technicals
8-day SMA
Sell
Level
$15.15
200-day SMA
Buy
Level
$14.07
Bollinger Bands (100)
Buy
Level
12.76 - 14.5
Chaikin Money Flow
Sell
Level
-7.1M
20-day SMA
Buy
Level
$14.90
Relative Strength Index (RSI14)
Buy
Level
55.94
ADX Line
Sell
Level
24.13
Williams %R
Neutral
Level
-52.3077
50-day SMA
Buy
Level
$14.28
MACD (12, 26)
Buy
Level
0.31
25-day Aroon Oscillator
Buy
Level
76
On Balance Volume
Neutral
Level
3M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.0072)
Sell
CA Score
(Annual)
Level (-0.5322)
Buy
Beneish M-Score
(Annual)
Level (-2.534)
Buy
Momentum Score
Level (6)
Buy
Ohlson Score
Level (-0.1204)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Kirin is the second-largest brewer in Japan with a 28% market share. It holds a top share in the happoshu (low-malt beer) and new genre (no-malt beer) categories. Apart from beer, it also operates a wide range of alcoholic and soft beverage products in Japan. It has made several acquisitions, including Lion Nathan and National Foods in Australia, the second-largest Brazilian brewer Schincariol and Myanmar’s biggest brewer over the past decade. It sold the businesses in Brazil and Myanmar in 2017 and 2023, respectively. In 2023, the company made a tender offer to bring Fancl on as a wholly owned subsidiary. Its revenue accounts for roughly 5% of Kirin’s total sales. Its overseas business, which includes alcoholic and nonalcoholic beverages, represents about 40% of the group’s sales.
Stock Forecast FAQ
In the current month, KNBWY has received 0 Buy ratings 1 Hold ratings, and 0 Sell ratings. The KNBWY average analyst price target in the past 3 months is $16.60.
-
Where Will Kirin Holdings Stock Be In 1 Year?
According to analysts, the consensus estimate is that Kirin Holdings share price will rise to $16.60 per share over the next 12 months.
-
What Do Analysts Say About Kirin Holdings?
Analysts are divided on their view about Kirin Holdings share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Kirin Holdings is a Sell and believe this share price will drop from its current level to $16.60.
-
What Is Kirin Holdings's Price Target?
The price target for Kirin Holdings over the next 1-year time period is forecast to be $16.60 according to 1 Wall Street analyst, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is KNBWY A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Kirin Holdings is a Hold. 1 of 1 analysts rates the stock a Hold at this time.
-
How Can I Buy Shares Of KNBWY?
You can purchase shares of Kirin Holdings via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Kirin Holdings shares.
-
What Is The Kirin Holdings Share Price Today?
Kirin Holdings was last trading at $14.95 per share. This represents the most recent stock quote for Kirin Holdings. Yesterday, Kirin Holdings closed at $15.02 per share.
-
How To Buy Kirin Holdings Stock Online?
In order to purchase Kirin Holdings stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire The Best Stock to Buy in a Bad Market?
Berkshire Hathaway (NYSE:BRK.A, BRK.B) has historically been one of the…
Is Shopify Stock Still a Buy in 2025 or Has Growth Peaked?
The big picture trends in e‑commerce sales are clearly in…
Stock Ideas
Buy
71
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
63
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Buy
60
RGC alert for May 6
Regencell Bioscience Holdings [RGC] is up 73.72% over the past day.
Buy
63
SKX alert for May 6
Skechers USA [SKX] is down 0.07% over the past day.
Sell
20
PTCT alert for May 6
PTC Therapeutics [PTCT] is down 11% over the past day.
